Printer Friendly

Browse Ovarian cancer topic

Care and treatment subtopic

Articles

1-300 out of 386 article(s) nextnext page
Title Author Type Date Words
BeiGene announces acceptance of NDA of pamiparib in ovarian cancer. Jul 17, 2020 166
Roche's Tecentriq Fails To Meet Ovarian Cancer Study Primary Endpoint. Jul 13, 2020 287
Should all patients with advanced ovarian cancer receive frontline maintenance therapy? Rossi, Emma Jun 1, 2020 1388
IMV Inc. reports updated clinical response, data from DeCidE1 study. May 29, 2020 320
ImmunoGen announces initial data from FORWARD II study at ASCO. May 29, 2020 276
Don't delay seeking help from GP; cancer patient's advice to anyone with symptoms. DANIEL HOLLAND daniel.holland@reachplc.com @danhollandnews May 7, 2020 677
If I'd put off getting checked, my cancer would have killed me. DANIEL HOLLAND Reporter daniel.holland@ncjmedia.co.uk May 7, 2020 684
GlaxoSmithKline's Zejula Gets New US Approval In Ovarian Cancer. Apr 30, 2020 272
Sutro Biopharma provides updated interim data for STRO-002. Apr 27, 2020 416
Celsion announces initial results from Phase I of Phase I/II OVATION 2 study. Mar 19, 2020 520
VBL Therapeutics expects interim analysis of OVAL Phase 3 study in 1Q20. Mar 19, 2020 174
NuCana reports preliminary data from study of NUC-1031 in ovarian cancer. Report Mar 10, 2020 398
Gynecologic cancer. Zhou, Zhen Ni; Wright, Jason D. Mar 1, 2020 3294
Study Suggests Delta-Tocotrienol in Combination with Standard Therapy Increased Survival in Refractory Ovarian Cancer Patients. Feb 1, 2020 819
Lynparza regulatory submission granted Priority Review in the US for 1st-line maintenance treatment with bevacizumab in advanced ; Submission based on Phase III PAOLA-1 trial for patients with advanced ovarian cancer regardless of biomarker status or ... Jan 13, 2020 264
Should secondary cytoreduction be performed for platinum-sensitive recurrent ovarian cancer? Toboni, Michael D.; Mutch, David G. Clinical report Jan 1, 2020 1654
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer; Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations. Dec 18, 2019 293
AstraZeneca's presence in China boosted by Lynparza approval for ovarian cancer. Dec 6, 2019 347
How should we monitor for ovarian cancer recurrence? Rossi, Emma Dec 1, 2019 1152
Celsion says DSMB recommends continuation of GEN-1 at 100mg/m2 dose. Nov 5, 2019 455
Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Zhang, Miaomiao; Zhao, Bing; Xie, Jing; Liang, Yan; Yang, Zaixing Nov 1, 2019 4100
What Medical-Surgical Nurses Need to Know About Caring for Patients with Epithelial Ovarian Cancer: Part II. Bohnenkamp, Susan; McClung, Emily; Bohnenkamp, Zachary Nov 1, 2019 4241
Establishment of primary human epithelial ovarian cancer cells and their application to cytotoxicity assessment. Wang, Chun-Kai; Lin, Cheng-Kuo; Huang, Li-Chun; Chou, Ssu-Jen; Lin, Chi-Kang; Chang, Cheng-Chang Disease/Disorder overview Nov 1, 2019 2362
MaxCyte increases dose level for mesothelioma and ovarian cancer patients in its Phase I trials. Oct 25, 2019 134
MaxCyte increases dose level for mesothelioma and ovarian cancer patients in its Phase I trials. Oct 25, 2019 132
ChemioCare begins dosing humans with its Olanzapine-based therapy. Oct 8, 2019 155
Pressure BioSciences' pressure cycling technology on display at international cancer conference. Conference news Oct 2, 2019 471
CPH-I and HE4 Are More Favorable Than CA125 in Differentiating Borderline Ovarian Tumors from Epithelial Ovarian Cancer at Early Stages. Wang, Zhiheng; Tao, Xiang; Ying, Chunmei Oct 1, 2019 5542
Lynparza improved the time women lived without disease progression to 22 months in the broad population and to 37 months in HRD-positive patients as 1st-line maintenance treatment with bevacizumab for newly-diagnosed advanced ovarian cancer. Sep 30, 2019 712
Drug niraparib benefits women newly diagnosed with advanced ovarian cancer: study. ANI Sep 29, 2019 480
What Medical-Surgical Nurses Need to Know About Caring for Patients with Epithelial Ovarian Cancer: Part I. Bohnenkamp, Susan; McClung, Emily; Bohnenkamp, Zachary Sep 1, 2019 3555
Glutathione peroxidase in ovarian cancer patients in Indonesia. Handayani, E.; Edianto, D.; Sahil, M.F.; Barus, R.P.; Tobing, C.L.; Ardiansyah, E.; Yaznil, M.R. Sep 1, 2019 2439
Baseline SUV Range for Liver and Blood Pool in Patients Undergoing F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography/F-18 FDG PET/BT Cekilen Hastalarda Karaciger ve Kan Havuzu icin Bazal SUV Araligi. Parlak, Yasemin; Goksoy, Didem; Mutevelizade, Gozde; Gumuser, Gul; Sayit, Elvan Sep 1, 2019 3104
PS4m boost for cancer experts. Aug 9, 2019 227
Celsion says GEN-1 immunotherapy highlighted in Oppenheimer expert call. Aug 9, 2019 336
TOP NEWS: AstraZeneca In Positive Results From Lynparza Cancer Trial. Aug 7, 2019 285
Aravive announces preliminary efficacy data from ongoing tril of AVB-500. Jul 31, 2019 189
GlaxoSmithKline (LSE: GSK) - GSK announces positive headline results in Phase 3 PRIMA study of ZEJULA (niraparib) for patients with ovarian cancer in the first line maintenance setting -- 15/7/2019. Clinical report Jul 16, 2019 169
Mereo BioPharma, FDA discuss design outline for Phase 2 trial of navicixizumab. Jul 15, 2019 320
Low Vaginal Bacteria Level Might Up Ovarian Cancer Risk, Study Says. Jul 10, 2019 481
Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer Patients with Low CA125 Concentration. Zhang, Hongyan; Huo, Qianyu; Huang, Lunhui; Cheng, You; Liu, Yunde; Bao, Huijing Jul 1, 2019 4229
US FDA grants priority review designation for Tesaro's Zejula. Jun 26, 2019 285
US FDA grants priority review designation for Tesaro's Zejula. Jun 26, 2019 281
AstraZeneca and US Merck's Lynparza Approved in Japan as First-Line Maintenance Therapy in Patients with BRCA-Mutated Advanced Ovarian Cancer. Jun 25, 2019 139
Lynparza Approved in the EU for Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer. Jun 21, 2019 163
Cancer sufferer given months to live defies diagnosis to survive 'against all odds'; Amelia Page is receiving a pioneering form of treatment to tackle disease. Jun 21, 2019 764
AstraZeneca announces Japanese approval for Lynparza for first-line maintenance. Jun 20, 2019 237
AstraZeneca announces Japanese approval for Lynparza for first-line maintenance. Jun 20, 2019 233
AstraZeneca reports approval for Lynparza in the EU for first -line maintenance treatment of BRCA-mutated advanced ovarian cancer. Jun 19, 2019 300
AstraZeneca reports approval for Lynparza in the EU for first -line maintenance treatment of BRCA-mutated advanced ovarian cancer. Jun 19, 2019 296
TOP NEWS: EU Approve AstraZeneca's Lynparza In Advanced Ovarian Cancer. Jun 18, 2019 322
AstraZeneca - Lynparza achieved a 72% objective response rate in patients with relapsed, germline BRCA-mutated advanced ovarian cancer -- 3/6/2019. Jun 4, 2019 429
Natera's Signatera test detects immunotherapy treatment response in new study. Jun 3, 2019 172
Clovis says Rubraca 'significantly improved' exploratory endpoints. Jun 2, 2019 243
Clovis announces expanded Rubraca data from ARIEL3, TRITON2 trials. Jun 2, 2019 479
Challenges in Managing Patients with Hereditary Cancer at Gynecological Services. Ueda, Mako; Tsubamoto, Hiroshi; Kashima-Morii, Mina; Torii, Yoshitaka; Kamihigashi, Mariko; Wakimoto Jun 1, 2019 5280
Does BRCA gene mutation affect comorbidity in patients with breast cancer? Topaloglu, Ulas Serkan; Kiraz, Aslihan Jun 1, 2019 254
PROGNOSTIC SIGNIFICANCE OF CYTOREDUCTIVE THERAPY OF OVARIAN CANCER--EASTERN CROATIA EXPERIENCE. Topolovec, Zlatko; Horvat, Teodora; Vidosavljevic, Domagoj; Sijanovic, Sinisa; Muller-Vranjes, Andri Jun 1, 2019 4328
Ride for Hope aids ovarian cancer patients. May 21, 2019 425
Clovis says Rubraca increased symptom-free period in ovarian cancer patients. Clinical report May 20, 2019 126
Transgene Receives FDA IND Clearance for Lead MyvacIndividualized Immunotherapy, TG4050, to Commence Clinical Development in Ovarian Cancer. May 16, 2019 474
Stephenson Cancer Center's Walker is senior author of study. May 7, 2019 359
Medical Advances in Ovarian Cancer: Oncologists are making strides toward earlier diagnosis and treatment. Disease/Disorder overview May 1, 2019 776
European Medicines Agency's committee adopts positive opinion for AstraZeneca and Merck's LYNPARZA for ovarian cancer. May 1, 2019 183
European Medicines Agency's committee adopts positive opinion for AstraZeneca and Merck's LYNPARZA for ovarian cancer. May 1, 2019 179
Syros Pharmaceuticals plans to report data from Phase 1 trial of SY-1365 in Q4. May 1, 2019 189
Performance of the MasSpec Pen for Rapid Diagnosis of Ovarian Cancer. Sans, Marta; Zhang, Jialing; Lin, John Q.; Feider, Clara L.; Giese, Noah; Breen, Michael T.; Sebasti May 1, 2019 6265
AstraZeneca - Lynparza receives positive EU CHMP opinion for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer -- 29/4/2019. Disease/Disorder overview Apr 30, 2019 422
Lynparza Receives Positive EU CHMP Opinion for First-Line Maintenance Treatment in BRCA-Mutated Advanced Ovarian Cancer. Apr 30, 2019 177
Merck and AstraZeneca's Lynparza granted positive EU opinion in ovarian cancer. Apr 29, 2019 180
Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process. McGee, Jacob; Peart, Teresa M.; Foley, Norine; Bertrand, Monique; Prefontaine, Michel; Sugimoto, Aki Apr 1, 2019 4855
Oasmia Pharmaceutical announces receipt of positive opinion from the EMA to add efficacy data to the approved Apealea product information. Mar 26, 2019 256
Oasmia Pharmaceutical announces receipt of positive opinion from the EMA to add efficacy data to the approved Apealea product information. Mar 26, 2019 257
Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer. Mar 25, 2019 457
Novocure initiates Phase 3 trial in recurrent ovarian cancer. Mar 22, 2019 136
Clovis Oncology's Rubraca Tablets Available for Women with Relapsed Ovarian Cancer in Germany. Mar 5, 2019 494
HISTOPATHOLOGICAL STUDY OF OVARIAN TUMOURS. Mallika, B.; Chakravarthy, V. Kalyan; Rao, D. Ranga Report Mar 4, 2019 2241
Gynecologic cancer. Gamble, Charlotte; Wright, Jason D. Mar 1, 2019 3004
AIVITA announces completion of treatment of its first ovarian cancer patient. Feb 22, 2019 280
AIVITA announces completion of treatment of its first ovarian cancer patient. Feb 22, 2019 276
Precigen Inc passes US FDA IND application for PRGN-3005 for advanced-stage platinum-resistant ovarian cancer. Feb 12, 2019 230
Precigen Inc passes US FDA IND application for PRGN-3005 for advanced-stage platinum-resistant ovarian cancer. Feb 12, 2019 226
The Role of [.sup.18]F-FDG PET/CT in Detecting Ovarian Cancer Recurrence in Patients with Elevated CA-125 Levels/CA-125 Duzeylerinde Artis Olan Over Kanserli Hastalarda Rekurrens Saptamada [.sup.18]F-FDG PET/BT'nin Rolu. Cengiz, Arzu; Koc, Zehra Pinar; Kara, Pelin Ozcan; Yurekli, Yakup Feb 1, 2019 3938
IMV Inc reports clinical update for DPX-Survivac program following FDA feedback. Jan 29, 2019 311
THE RELATION BETWEEN CA 125, CECT ABDOMEN & PELVIS AND HISTOPATHOLOGICAL FEATURES IN OVARIAN NEOPLASMS. Prakash, S.S.; Antony, Charles Jude; Ashwini B.G. Report Jan 21, 2019 3308
Frozen Section Diagnosis of Ovarian Epithelial Tumors: Diagnostic Pearls and Pitfalls. Buza, Natalia Report Jan 1, 2019 8234
Myxoma of the Ovary: in Regard to Bedir et al. (Balkan Med J 2018;35:120-121). Sterkers, Nicolas; Salvat, Francis; Sappa, Philippe; Donnez, Olivier Clinical report Jan 1, 2019 1427
US FDA Accepts Regulatory Submission For Lynparza Maintenance Therapy in Newly-Diagnosed, BRCA-mutated Advanced Ovarian Cancer and Grants Priority Review. Nov 16, 2018 218
AstraZeneca and Merck announces acceptance by US FDA of regulatory submission for Lynparza. Nov 13, 2018 497
AstraZeneca and Merck announces acceptance by US FDA of regulatory submission for Lynparza. Nov 13, 2018 498
'Woeful lack of awareness' delays ovarian ca diagnosis. Franki, Richard Nov 1, 2018 643
Association of BRCA1 185 del AG with early age onset of breast cancer patients in selected cohort from Pakistani population. Oct 31, 2018 2077
Celsion announces progression-free survival data from OVATION I study. Oct 24, 2018 215
AstraZeneca and Merck announce Lynparza trial shows 70% reduction in PFS ovarian cancer. Oct 23, 2018 437
Lynparza phase III trial indicates decreased risk of disease progression or death in BRCA-mutated ovarian cancer patients. Oct 23, 2018 165
AstraZeneca and Merck announce Lynparza trial shows 70% reduction in PFS ovarian cancer. Oct 23, 2018 433
Lynparza phase III trial indicates decreased risk of disease progression or death in BRCA-mutated ovarian cancer patients. Oct 23, 2018 161
Solo-1 Phase III Trial Demonstrates Lynparza Maintenance Therapy Cut the Risk of Disease Progression or Death by 70% in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer. Oct 23, 2018 143
Zai Lab announces approval of Zejula for patients with relapsed ovarian cancer. Oct 22, 2018 237
OncoMed announces interim phase 1b results for Navicixizumab, Paclitaxel combo. Financial report Oct 21, 2018 158
Clovis receives Breakthrough Therapy Designation for Rubraca. Oct 2, 2018 226
OncoMed announces publication of Phase 1a data for navicixizumab. Sep 24, 2018 269
AIVITA Biomedical treats first patient under the Phase 2 ovarian cancer trial. Sep 21, 2018 240
YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer/Seroz epitelyal over kanserinde tanida, prognoz ve platin duyarliligi ongorusunde YKL-40 kullanimi. Kahramanoglu, Ilker; Tokgozoglu, Nedim; Turan, Hasan; Sal, Veysel; Simsek, Gonul; Gelisgen, Remise; Sep 1, 2018 3496
Cancer pattern among newly registered patients in a cancer hospital of South Gujarat. Patel, Ketankumar; Patel, Hiteshree; Chaudhari, Vipul; Mehariya, Sachin Report Sep 1, 2018 3269
Synchronous endometrioid carcinoma of bilateral ovaries and uterus: A case report. Shah, Neeta C.; Polra, Jatin H. Case study Sep 1, 2018 1844
Zai Lab announces completion of ZL-2306 study for ovarian cancer patients. Aug 20, 2018 177
Clovis announces first patient in ATHENA trial of Rubraca and Opdivo. Aug 8, 2018 182
Novocure Publishes Results of Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Cancer. Clinical report Aug 1, 2018 325
Zai Lab doses first patient in Phase 3 China registration trial of ZL-2306. Jun 29, 2018 157
Phase II Trial of Aivita's Patient-specific Ovarian Cancer Vaccine Begins with First Patient. Clinical report Jun 20, 2018 234
Hudiburg Subaru donates to cancer care nonprofit. Jun 6, 2018 176
Oophorectomy for premenopausal breast cancer. Rossi, Emma Jun 1, 2018 1414
Incidence of suspicious axillary lymph node involvement in fluorine-18 fluoro-D-glucose positron emission tomography/computed tomography in gynecologic cancers/Jinekolojik kanserlerde flor-18 floro-D-glukoz pozitron emisyon tomografisi-bilgisayarli tomografide supheli aksiller lenf nodu tutulumunun insidansi. Raoufi, Jalal; Iscan, Serhan Can; Hanedan, Candost; Ozkan, Emine Elif; Cerci, Sevim Sureyya; Erdemog Report Jun 1, 2018 3694
The European Medicines Agency approves AstraZeneca and Merck's Lynparza tablets for certain ovarian cancers. May 10, 2018 156
The European Medicines Agency approves AstraZeneca and Merck's Lynparza tablets for certain ovarian cancers. May 10, 2018 152
Iovance Biotherapeutics reports Q1 EPS (31c), consensus (30c). Financial report May 10, 2018 118
AstraZeneca reports EU approval for Lynparza for certain ovarian cancers. May 8, 2018 135
AstraZeneca and MSD's Lynparza gets further European approval. May 8, 2018 281
AstraZeneca and MSD's Lynparza gets further European approval. May 8, 2018 277
ImmunoGen Completes Interim Analysis of Phase 3 Trial of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer. May 1, 2018 333
Tarveda Therapeutics Initiates Phase 1/2a Study of PEN-866 for Patients with Solid Malignancies. Apr 26, 2018 232
Tesaro announces 'positive' top-line results from QUADRA trial of ZEJULA. Apr 24, 2018 238
On Target Laboratories treats first ovarian cancer patient under Pivotal Phase 3 OTL38 trial. Apr 6, 2018 214
On Target Laboratories treats first ovarian cancer patient under Pivotal Phase 3 OTL38 trial. Apr 6, 2018 210
Chlamydia infections associated with more than a doubling of ovarian cancer risk. Sullivan, Michele G. Apr 1, 2018 536
ImmunoGen Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab Demonstrates Efficacy and Safety in Platinum-Resistant Ovarian Cancer. Mar 28, 2018 343
Clovis Oncology Commences European Early Access Program for Rucaparib in Recurrent Ovarian Cancer. Mar 27, 2018 287
Multiple Bilateral Ovarian Mature Cystic Teratomas with Ovarian Torsion: A Case Report. Fayez, Iman; Khreisat, Basel; Athamneh, Tarek; Omoosh, Reema; Daibes, Mayada A. Case study Mar 1, 2018 2092
CHMP Issues Positive Opinion for Lynparza (olaparib) as Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer. Feb 28, 2018 254
Northwell names top Sloan Kettering doc to lead cancer ops. Feb 15, 2018 345
Lynparza Approved in Japan as Maintenance Treatment for Women with Platinum-Sensitive Relapsed Ovarian Cancer Regardless of BRCA Mutation Status. Jan 22, 2018 525
Japanese approval for AstraZeneca's Lynparza for advanced ovarian cancer. Jan 19, 2018 199
Japanese approval for AstraZeneca's Lynparza for advanced ovarian cancer. Jan 19, 2018 195
2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations. Halkia, Evgenia; Chrelias, George; Chrelias, Charalambos; Esquivel, Jesus Jan 1, 2018 4922
Experience and Expectations of Ovarian Cancer Patients in Australia. Holliday, Catherine M.; Morte, Maria; Byrne, Josephine M.; Holliday, Anne T. Jan 1, 2018 5967
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women? Abdalla, Nabil; Piorkowski, Robert; Bachanek, Michal; Stanirowski, Pawel; Cendrowski, Krzysztof; Saw Clinical report Jan 1, 2018 7536
NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib. Kankia, Ibrahim H.; Khalil, Hilal S.; Langdon, Simon P.; Moult, Peter R.; Bown, James L.; Deeni, Yus Jan 1, 2018 11474
Use of Chinese Herbal Medicine Improves Chemotherapy-Induced Thrombocytopenia among Gynecological Cancer Patients: An Observational Study. Wu, Yi-Hong; Chen, Hsing-Yu; Lai, Chyong-Huey; Yeh, Chein-Shuo; Pang, Jong-Hwei S.; Qiu, Jian-Tai; C Report Jan 1, 2018 5401
Pelvic Tuberculosis Diagnosed during Operative Laparoscopy for Suspected Ovarian Cancer. Martingano, Daniel; Cagle-Colon, Kayla; Chiaffarano, Jeanine; Marcus, Alan; Contreras, Diana Jan 1, 2018 1724
Diagnosis and Management of Ovarian Tumor in Mayer-Rokitansky-Kuster-Hauser (MRKH) Syndrome. Miao, Yali; Wen, Jirui; Huang, Liwei; Wu, Jiang; Zhao, Zhiwei Disease/Disorder overview Jan 1, 2018 3119
AIVITA Biomedical enrols first ovarian cancer patient under Phase II clinical 'ROOT OF CANCER' trial. Dec 21, 2017 277
ASK DR. ETINGIN: Aspirin for cancer prevention ... Radiation therapy for breast cancer ... Nordic walking. Etingin, Orli R. Oct 1, 2017 650
Genelux doses first patient with recurrent ovarian cancer with GL-ONC1 at Florida Hospital Cancer Institute (FHCI). Sep 28, 2017 251
Bristol-Myers Squibb, Clovis Oncology. Sep 1, 2017 468
THE USE OF INFERIOR VENA CAVA FILTERS BEFORE SURGERY IN WOMEN WITH OVARIAN CANCER WITH THE INITIAL SYMPTOM OF DEEP VENOUS THROMBOSIS: CASE REPORT AND REVIEW OF LITERATURE. Adam, Visnja Nesek; Bulic, Antonia; Jokic, Aleksandra; Osmancevic, Nedzad; Matolic, Martina; Brozovi Case study Sep 1, 2017 2471
Ovarian metastasis of Mullerian adenosarcoma of the cervix with sarcomatous overgrowth/Serviksin sarkomatoz gelisim gosteren Mullerian adenosarkomunda over metastazi. Koyuncuoglu, Meral; Saatli, Bahadir; Yildirim, Nuri Clinical report Sep 1, 2017 2042
Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-[beta]1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers/Endometrial ve Ovaryum Kanserinde Tanisal Deger Yonunden Serum Biyobelirteci Olarak Vitronektin, Solubl Epitel-Kaderin ve TGF-[beta]1'in Degerlendirilmesi. Turan, Taylan; Torun, Meral; Atalay, Funda; Gonenc, Aymelek Report Aug 1, 2017 4480
Major breakthrough in cancer trial hailed. Jun 4, 2017 131
Researchers toast ovarian cancer breakthrough. Jun 3, 2017 259
Are Johnson & Johnson Products Safe? May 17, 2017 598
Mateon Therapeutics reveals data from phase 2/3 trial of CA4P in platinum resistant ovarian cancer patients. Apr 20, 2017 203
Mateon Therapeutics reveals data from phase 2/3 trial of CA4P in platinum resistant ovarian cancer patients. Apr 20, 2017 199
'I just thought university life was taking its toll but it was ovarian cancer' SEREN HAS SHARED HER STORY IN HOPE OTHER WOMEN GET CHECKED. Mar 13, 2017 634
MRI classification and characterization of complex ovarian masses. Halankar, Jaydeep Report Mar 1, 2017 2776
Ovarian cancer. Wright, Jason D.; Buskwofie, Ama C. Mar 1, 2017 2913
First Patient Dosed in ImmunoGen Phase 3 Study of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer. Jan 27, 2017 376
Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer. Waki, Kayoko; Kawano, Kouichiro; Tsuda, Naotake; Ushijima, Kimio; Itoh, Kyogo; Yamada, Akira Report Jan 1, 2017 4699
Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients. Halvorsen, Ann Rita; Kristensen, Gunnar; Embleton, Andy; Adusei, Cybil; Barretina-Ginesta, Maria Pil Report Jan 1, 2017 5663
HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases. Chudecka-Glaz, Anita; Cymbaluk-Ploska, Aneta; Strojna, Aleksandra; Menkiszak, Janusz Report Jan 1, 2017 8390
Internal Jugular and Subclavian Vein Thrombosis in a Case of Ovarian Cancer. Moriwaki, Hiroto; Hayama, Nana; Morozumi, Shouko; Nakano, Mika; Nakayama, Akari; Takahata, Yoshiomi; Case study Jan 1, 2017 3128
Neutrophil-to-Lymphocyte Ratio Is a Potential Prognostic Biomarker in Patients with Ovarian Cancer: A Meta-Analysis. Chen, Shubo; Zhang, Liu; Yan, Guangyue; Cheng, Sijin; Fathy, Abdel Hamid; Yan, Nana; Zhao, Yongzhao Report Jan 1, 2017 5558
Therapy Effects of Wogonin on Ovarian Cancer Cells. Ruibin, Jiang; Bo, Jin; Danying, Wan; Chihong, Zhu; Jianguo, Feng; Linhui, Gu Report Jan 1, 2017 4536
The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment. Varas-Godoy, Manuel; Rice, Gregory; Illanes, Sebastian E. Report Jan 1, 2017 6330
Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer. Canton-Romero, Juan Carlos; Miranda-Diaz, Alejandra Guillermina; Banuelos-Ramirez, Jose Luis; Carril Report Jan 1, 2017 6387
A Review of mTOR Pathway Inhibitors in Gynecologic Cancer. de Melo, Andreia Cristina; Paulino, Eduardo; Garces, Alvaro Henrique Ingles Report Jan 1, 2017 7070
Pediatric Ovarian Growing Teratoma Syndrome. Rentea, Rebecca M.; Varghese, Aaron; Ahmed, Atif; Kats, Alexander; Manalang, Michelle; Dowlut-McElro Clinical report Jan 1, 2017 4808
Three Cases of Pseudo-Meigs' Syndrome Secondary to Ovarian Metastases from Colorectal Cancer. Yamamoto, Yuta; Miyagawa, Yusuke; Ehara, Takehito; Koyama, Makoto; Nakamura, Satoshi; Takeuchi, Dais Clinical report Jan 1, 2017 3104
Contralateral Ovarian Metastasis of Clear-Cell Renal Carcinoma: A Rare Case Report and Review of the Literature. Uruc, Fatih; Akan, Serkan; Sahin, Aytac; Yildirim, Caglar; Urkmez, Ahmet Case study Jan 1, 2017 1680
Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing. Scoville, Delia J.; Uhm, Tae Kyu Brian; Shallcross, Jamie A.; Whelan, Rebecca J. Report Jan 1, 2017 6964
Potential Cure For Combat Aggressive Form Of Breast Cancer. Nov 1, 2016 327
Efficacy of Postoperative Hormone Replacement Therapy on Prognosis of Patients with Serous Ovarian Carcinoma. Zhang, Yong-Li; Chen, Jin-Hong; Lu, Wen; Li, Bi-Lan; Zhu, Qin-Yi; Wan, Xiao-Ping Report Nov 1, 2016 3634
Precision medicine and companion diagnostics join the battle against ovarian cancer. Mancini-DiNardo, Debora; Brown, Krystal Oct 1, 2016 1875
Better survival with primary surgery in stage MIC ovarian cancer. Osterweil, Neil Oct 1, 2016 489
'Cancer patients in England have better chance of survival' - report. Sep 21, 2016 634
Merck and Pfizer have initiated a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of avelumab in combination with, and/or as follow-on (maintenance) treatment to, platinum-based chemotherapy in patients with locally advanced or metastatic disease (Stage III or Stage IV) with previously untreated epithelial ovarian cancer. Sep 1, 2016 189
Association of high-grade serous ovarian carcinoma with intraepithelial carcinoma of fallopian tube. Chaudhary, Vijay Kumar; Solanki, Ranjana Sep 1, 2016 2158
Immunotherapy may be secret weapon in ovarian cancer. Aug 1, 2016 140
Merck and Pfizer announce Phase III study of Avelumab for ovarian cancer. Jul 7, 2016 219
Merck and Pfizer announce Phase III study of Avelumab for ovarian cancer. Jul 7, 2016 215
Oncology Company Novocure Enrolls Last Patient in Trial of Tumor Treating Fields in Ovarian Cancer. May 19, 2016 275
The impact of endometriosis on ovarian cancer. Miller, Charles E. Apr 1, 2016 338
Valproate, bipolar disorder and polycystic ovarian syndrome/Valproat, bipolarni poremecaj i sindrom policisticnih jajnika. Okanovic, Milana; Zivanovic, Olga Disease/Disorder overview Mar 1, 2016 4352
Ghrelin attenuates the growth of HO-8910 ovarian cancer cells through the ERK pathway. Bai, R.X.; Wang, W.P.; Zhao, P.W.; Li, C.B. Report Mar 1, 2016 2949
Increasing accuracy of diagnosis, prognosis. Brief article Feb 1, 2016 264
Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. Chen, Tze-Chien; Chien, Chih-Chiang; Wu, Ming-Shun; Chen, Yen-Chou Report Jan 15, 2016 5780
Frontier Pharma: Ovarian Cancer - Identifying and Commercializing First-in-Class Innovation. Jan 6, 2016 429
A rare location of metastasis in a patient with synchronous ovarian and breast neoplasia. Filip, Bogdan; Panuta, Andrian; Hutanu, Ionut; Buna-Arvinte, Mihaela; Ferariu, Dan; Scripcariu, Drag Case study Dec 1, 2015 1792
Oregon should do more to prevent and treat ovarian cancer. Oct 31, 2015 507
Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-[beta] signaling pathway. Kim, Ye-Seul; Choi, Kyung-Chul; Hwang, Kyung-A Report Oct 15, 2015 5419
Big C patients freeze ovaries and have baby after chemo. Oct 7, 2015 216
A Rare Case of Ovarian Cancer Presenting with Paraneoplastic Cerebellar Degeneration and Limbic Encephalitis. Li, Wei-Hua; Cao, Dong-Yan; Shen, Keng; Yang, Jia-Xin Clinical report Oct 5, 2015 1358
Combination therapy may be more effective against ovarian cancer. Oct 1, 2015 184
Effective, but underused ovarian cancer treatment. Brief article Oct 1, 2015 294
One-third of ovarian cancer patients survive for 10 or more years. Oct 1, 2015 173
[HbA.sub.1c] in patients with polycystic ovary syndrome: a potential marker of inflammation. Mortada, Rami; Kallail, Ken James; Dong, Frank; Karakas, Sidika Report Oct 1, 2015 2470
Tanshinone IIA enhances the effects of TRAIL by downregulating survivin in human ovarian carcinoma cells. Lin, Jyun-Yi; Ke, Yu-Min; Lai, Jui-Sheng; Ho, Tsing-Fen Report Sep 15, 2015 5350
Trocar site metastasis following robotic oophorectomy for ovarian cancer: a case report and review of the literature. Gauthier, Jason M.; Hauch, Adam; Duong, Buu T.; Crawford, Byron E.; Robinson, William R.; Kandil, Em Clinical report Sep 1, 2015 1721
Survival impact of secondary cytoreductive surgery for recurrent ovarian cancer in an Asian population. Bhat, Rani Akhil; Chia, Yin Nin; Lim, Yong Kuei; Yam, Kwai Lam; Lim, Cindy; Teo, Melissa Report Sep 1, 2015 6750
Menopausal hormone use and ovarian cancer risk. Abstract Sep 1, 2015 797
Low Programmed Cell Death 5 Expression is a Prognostic Factor in Ovarian Cancer. Gao, Li; Ye, Xue; Ma, Rui-Qiong; Cheng, Hong-Yan; Han, Hong-Jing; Cui, Heng; Wei, Li-Hui; Chang, Xia Report Aug 1, 2015 3754
Meigs' syndrome in an elderly woman with short of breath. Tsai, Wan-Chen; Chang, Fung-Wei; Chang, Junn-Liang; Chao, Hong-Ming Disease/Disorder overview May 1, 2015 1329
Companion diagnostics: the key to personalized treatment of breast and ovarian cancer. Lanchbury, Jerry Apr 1, 2015 1261
Hormone therapy tied to ovarian cancer. Krisberg, Kim Apr 1, 2015 206
Monitored growth and ovary condition of grass shrimp kept under laboratory conditions. Humphries, Kirsten N.; Rayburn, James R. Report Apr 1, 2015 289
Primary fallopian tube carcinoma: case report. Onimi, Syamala; Godla, Usha Rani Mar 16, 2015 988
Do the benefits of HRT outweigh the risks of ovarian cancer? Mar 1, 2015 198
Insys Therapeutics wins US FDA's orphan drug designation for Liposomal Encapsulated Paclitaxel for ovarian cancer. Jan 27, 2015 181
Insys Therapeutics wins US FDA's orphan drug designation for Liposomal Encapsulated Paclitaxel for ovarian cancer. Jan 27, 2015 177
Cytotoxic effects of stem bark extracts and pure compounds from Margaritaria discoidea on human ovarian cancer cell lines. Johnson-Ajinwo, Okiemute Rosa; Richardson, Alan; Li, Wen-Wu Jan 15, 2015 2628
Depression, anxiety, and anger in patients with polycystic ovary syndrome/Polikistik over sendromu olan hastalarda depresyon, anksiyete ve ofke. Balikci, Adem; Erdem, Murat; Keskin, Ugur; Zincir, Selma BOZKURT; Gulsun, Murat; Ozcelik, Fatih; Akg Report Dec 1, 2014 3798
Ovarian cancer: the ability to detect small amounts of tumor cells in blood and vaginal specimens offers big advances in diagnosis and treatment for this deadly malignancy. Divine, Laura; Mutch, David G. Oct 1, 2014 1682
New blood test could offer more tailored treatment of ovarian cancer. Brief article Oct 1, 2014 213
Cure for most lethal gynecologic cancer? Brief article Oct 1, 2014 292
Myriad's Tumor BRACAnalysis CDx test improves by 44% detection of BRCA 1/2 mutations in ovarian cancer patients. Sep 29, 2014 281
Intravenous Aacorbate in the Treatment of Ovarian Cancer: based on interviews with Nancy Faass. Drisko, Jeanne; Chen, qi Aug 1, 2014 3372
Letrozole Facilitates Pregnancy in Women Suffering from Polycystic Ovary Syndrome (PCOS). Jul 17, 2014 306
Caris Life Sciences unveils positive clinical data for tumour profiling service in ovarian cancer. Clinical report Jun 5, 2014 330
Ovarian/adnexal masses in the nonpregnant female patient. McGahan, John P.; Corwin, Michael T.; Gerscovich, Eugenio O. Report May 1, 2014 2731
The use of antioxidant loaded TCP devices to suppress the metabolic activity of SK-OV-3 ovarian cancer like cells. Harpole, Jennifer L.; Tucci, Michelle Report Apr 1, 2014 1616
The use of antioxidants to suppress the SK-OV-3 cell line in ovarian cancer. Harpole, Jennifer L.; Tucci, Michelle; Benghuzzi, Hamed Report Apr 1, 2014 1805
A rare case of ovarian hyperstimulation after clomiphene citrate resulting in torsion and rupture. Rukshana; Devi, S. Suganya; Syamala; Rani, Usha Mar 3, 2014 1541
Topoisomerase I inhibitor suppress tumor growth in chemoresistant ovarian cancer-initiating cells. Wang, Yu-Chi; Chang, Cheng-Chang; Chiang, Kai-Jo; Chao, Tai-Kuang; Wu, Chia-Chun; Chang, Ping-Ying; Report Mar 1, 2014 2426
Precision Therapeutics' ChemoFx test can find resistance to first-line therapy in ovarian cancer patients. Feb 24, 2014 145
It took a year and a hospital sit-in to finally find out I had terminal cancer. A simple test would have given me a fighting chance. Feb 15, 2014 868
Cell counts provide a read on ovarian cancer. Seppa, Nathan Brief article Jan 11, 2014 142
Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. Jan 10, 2014 233
Synta Pharmaceuticals Corp to start pan-European Study of ganetespib in p53 mutant, metastatic ovarian cancer patients. Jan 10, 2014 229
Laparoscopic approach to a large ovarian fibroma: a case report. Najmi, Zahra; Mehdizadehkashi, Abolfazl; Kadivar, Maryam; Tamannaie, Zeinab; Chaichian, Shahla Case study Jan 1, 2014 1685
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer. Kuhlmann, Jan Dominik; Baraniskin, Alexander; Hahn, Stephan A.; Mosel, Frank; Bredemeier, Maren; Wim Report Jan 1, 2014 4953
Genetic variants in the fibroblast growth factor pathway as potential markers of ovarian cancer risk, therapeutic response, and clinical outcome. Meng, Qing H.; Xu, Enping; Hildebrandt, Michelle A.T.; Liang, Dong; Lu, Karen; Ye, Yuanqing; Wagar, Report Jan 1, 2014 6577
Primary fallopian tube carcinoma arising in the setting of chronic pelvic inflammatory disease. Zardawi, Ibrahim M. Case study Jan 1, 2014 3350
Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells. Gong, Li-Hua; Chen, Xiu-Xiu; Wang, Huan; Jiang, Qi-Wei; Pan, Shi-Shi; Qiu, Jian- Ge; Mei, Xiao-Long; Report Jan 1, 2014 3799
Role of JNK activation and mitochondrial Bax translocation in allicin- induced apoptosis in human ovarian cancer SKOV3 cells. Xu, Ling; Yu, Jin; Zhai, Dongxia; Zhang, Danying; Shen, Wei; Bai, Lingling; Cai, Zailong; Yu, Chaoqi Report Jan 1, 2014 2913
Evaluating cytotoxicity of hyaluronate targeted solid lipid nanoparticles of etoposide on SK-OV-3 cells. Ghalaei, Parviz Mohammadi; Varshosaz, Jaleh; Aliabadi, Hojatollah Sadeghi Report Jan 1, 2014 4655
Standardization of laparoscopic pelvic examination: a proposal of a novel system. Bedaiwy, Mohamed A.; Pope, Rachel; Henry, Drisana; Zanotti, Kristin; Mahajan, Sangeeta; Hurd, Willia Report Jan 1, 2014 1977
Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications. Iqbal, Nida; Iqbal, Naveed Report Jan 1, 2014 6577
Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer. Kim, Se Ik; Kim, Hee Seung; Kim, Tae Hun; Suh, Dong Hoon; Kim, Kidong; No, Jae Hong; Chung, Hyun Hoo Report Jan 1, 2014 5522
New device helps in ovarian cancer treatment. Dec 10, 2013 152
Glycotope begins Phase IIb study of PankoMab-GEX in ovarian cancer. Nov 25, 2013 200
Clovis Oncology Inc reports start of dosing of first patient with rucaparib in ovarian cancer in ARIEL2 study. Oct 31, 2013 228
Clovis Oncology Inc reports start of dosing of first patient with rucaparib in ovarian cancer in ARIEL2 study. Oct 31, 2013 224
Targeted treatment chemo combo prolongs lives of ovarian cancer sufferers. Oct 12, 2013 299
Low-grade variety can be tougher to cure. Brief article Oct 1, 2013 264
Masculinising ovarian steroid cell tumor in a 51 year old Indian female: a case report. Gurukiran, C.S.; Pavan, B.M.; Tauheed, Fahad; Naveen, Kumar M. Case study Aug 19, 2013 1852
TESARO Inc enrols first patient in Phase 3 trial of niraparib in ovarian cancer patients in NOVA Study. Jul 24, 2013 200
TESARO Inc enrols first patient in Phase 3 trial of niraparib in ovarian cancer patients in NOVA Study. Jul 24, 2013 196
Creactive protein and lipid profile in patients with polycystic ovary syndrome treated by metformin. Jun 30, 2013 3952
Array BioPharma Inc to launch global Phase 3 trial of MEK162 in patients with low-grade serous ovarian cancer. May 7, 2013 224
Array BioPharma Inc to launch global Phase 3 trial of MEK162 in patients with low-grade serous ovarian cancer. May 7, 2013 220
OXiGENE Inc concludes ZYBRESTAT Phase 2 trial enrolment at clinical sites in the US in ovarian cancer patients. Apr 25, 2013 219
OXiGENE Inc concludes ZYBRESTAT Phase 2 trial enrolment at clinical sites in the US in ovarian cancer patients. Apr 25, 2013 205
Preoperative evaluation of ovarian tumors in the rural population--clinical features, grey scale ultrasound, colour Doppler, serum CA-125 and Alcazar score in predicting malignancy. Sinha, Ananya; Hariharan, Chella; Chaudhary, Rahul K. Report Apr 22, 2013 4637
Long-term management of ovarian neoplasia in two cockatiels (Nymphicus hollandicus). Keller, Krista A.; Beaufrere, Hugues; Brandao, Joao; McLaughlin, Leslie; Bauer, Rudy; Tully, Thomas Case study Mar 1, 2013 5406
A retrospective study of borderline ovarian tumours. C., Nirmala; Desai, Ava D.; Patel, Shilpa M.; Dave, Kalpana S. Clinical report Feb 11, 2013 2136
Drug successfully treats low-grade ovarian cancer. Feb 9, 2013 462
Ovarian serous carcinoma associated with a distinct "corded and hyalinized" pattern. Estrella, Jeannelyn S.; Wolf, Judith K.; Deavers, Michael T. Case study Feb 1, 2013 3298
Targeted therapies for ovarian cancer may be in sight. Jan 21, 2013 345
Ovarian carcinosarcoma: effects of cytoreductive status and platinum-based chemotherapy on survival. Jernigan, Amelia M.; Fader, Amanda Nickles; Nutter, Benjamin; Rose, Peter; Tseng, Jill H.; Escobar, Report Jan 1, 2013 3388
Family history, symptoms key. Report Oct 1, 2012 284
Endocyte Inc receives supplemental supply of DOXIL in aid of ongoing Phase 3 PROCEED trial in ovarian cancer. Aug 3, 2012 153
Endocyte Inc receives supplemental supply of DOXIL in aid of ongoing Phase 3 PROCEED trial in ovarian cancer. Aug 3, 2012 149
Quinary debulking for epithelial ovarian cancer. Edwards, James M.; Lowery, William Jeffrey; Secord, Angeles Alvarez Case study Jul 1, 2012 1392
Femoral metastases from ovarian serous/endometroid adenocarcinoma. Beresford-Cleary, N.J.A.; Mehdi, S.A.; Magowan, B. Case study Jul 1, 2012 1142
Ovarian cancer: new studies add to our understanding of which women may benefit from screening. The goal of improving overall survival among women who have this malignancy is elusive, however. Novetsky, Akiva P.; Mutch, David G. Jul 1, 2012 354
When to consider PCOS in female acne patients. Wachter, Kerri Jun 1, 2012 427
Videoassisted ovariohysterectomy with two portals for pyometra's treatment in a bitch/Ovariohisterectomia videoassistida com dois portais para o tratamento de piometra em cadela. Guedes, Rogerio Luizari; Simeoni, Caroline Posser; Linhares, Marcella Teixeira; de Castr, Ialo Ferro Jun 1, 2012 2025
Antiproliferation effect of rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro. Tai, Joseph; Cheung, Susan; Wu, Matthew; Hasman, David Report May 1, 2012 5184
War on cancer. Moss, Ralph Apr 1, 2012 2168
Ovarian cancer drug slows disease progression. Mar 1, 2012 507
Avastin delays ovarian cancer progression. Dec 29, 2011 370
AstraZeneca not to advance ovarian cancer project. Dec 20, 2011 151
MabCure completes ovarian cancer diagnostic trial in Thailand. Dec 16, 2011 237
Common diabetes pill can cut risk of ovarian cancer by 40 pc. Nov 13, 2011 393
New UK guidelines on recognition and management of ovarian cancer. Report Nov 1, 2011 391
Genetic and molecular studies in ovarian cancer patients. Sowjanya, B. Lakshmi; Devi, P.K. Rudrama Report Oct 1, 2011 433
Cervical Cancer. Disease/Disorder overview Sep 1, 2011 9929
Ovarian Cancer. Disease/Disorder overview Sep 1, 2011 6261
Ovarian strumal carcinoid presenting as severe progressive constipation. Kachhawa, G.; Kumar, S.; Singh, G.; Mathur, S.; Kumar, L.; Sharma, J. Case study Aug 1, 2011 1451
Ovarian cancer: neoadjuvant chemotherapy may improve outcomes in women who have bulky, advanced ovarian cancer. Kizer, Nora; Mutch, David G. Jul 1, 2011 337
Neoadjuvant chemotherapy is an acceptable alternative to primary surgical cytoreduction. Jul 1, 2011 435
Neoadjuvant chemotherapy improves perioperative outcomes. Jul 1, 2011 272
In the pipeline: data on intraperitoneal chemotherapy after neoadjuvant chemotherapy. Jul 1, 2011 597
Hope for ovarian cancer sufferers; Faulty gene could hold key to which drugs will prove most effective. Jun 7, 2011 492
EntreMed's ENMD-2076 shows clinical activity in ovarian cancer patients. Jun 6, 2011 178
New insights into treatment of hereditary breast, ovarian cancer. May 28, 2011 195
Advanced ovarian cancer often treated suboptimally. McNamara, Damian May 1, 2011 888
Dysgerminoma with pregnancy and viable baby: a case report. Akhtar, Kafil; Ahmad, S. Shamshad; Kumar, Amit; Afshan, Noor Case study May 1, 2011 1878
FDA Could Approve Endocyte's EC145 to Treat Ovarian Cancer in Women: Analyst. Apr 25, 2011 642
ImmunoGen reports data for novel therapeutic for ovarian cancer. Apr 5, 2011 176
Advanced ovarian ca often treated suboptimally. Mcnamara, Damian Apr 1, 2011 1035
-Topotarget halts phase II study in ovarian cancer with belinostat. Mar 15, 2011 146
-Topotarget halts phase II study in ovarian cancer with belinostat. Mar 15, 2011 147
Rational care or rationing care? Updates and controversies in women's prevention. Davisson, Laura Report Jan 1, 2011 4054
Ovarian cancer. Disease/Disorder overview Dec 1, 2010 6273
Hope for ovarian cancer patients. Nov 8, 2010 196
Skilled us imaging of the adnexae: part 3: ovarian neoplasms: not all neoplasms represent cancer, and some have overlapping sonographic characteristics. Here's what you need to know to differentiate what is benign from what is malignant. Timor-Tritsch, Ilan E.; Goldstein, Steven R. Nov 1, 2010 1693
Amgen's drug candidate demonstrates antitumor activity in patients with ovarian cancer. Oct 11, 2010 282
Ovarian cancer: recent studies shed light on early detection of ovarian cancer--but it's not a green light for routine screening. Until promising avenues of research lead further, refer women who have an adnexal mass, an elevated CA-125 level, and troubling ultrasonographic findings to a specialist--early. Mutch, David G.; Kizer, Nora Brief article Jul 1, 2010 280
The effect of screening on ovarian cancer mortality remains unknown. Jul 1, 2010 436

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters